Clinical Characteristics and Prognosis of Patients with Hematological Malignancies Superimposed with Solid Tumors.
10.19746/j.cnki.issn.1009-2137.2022.03.042
- Author:
Lin GUI
1
;
Wei ZHANG
2
;
Jing Ning SHI
3
;
Wen Jing ZHANG
4
;
Zhi Nan YANG
4
;
Yong Chao MA
4
;
Bao An CHEN
5
Author Information
1. Department of Hematology， Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing 211100， Jiangsu Province, China,Department of Hematology, Zhongda Hospital Southeast University， Nanjing 210009, Jiangsu Province, China.
2. Department of Hematology， Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing 211100， Jiangsu Province, China,Email: zhangweizwmz@126.com.
3. Department of Hematology， Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing 211100， Jiangsu Province, China,Email: s8j8n8@126.com.
4. Department of Hematology， Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing 211100， Jiangsu Province, China.
5. Department of Hematology, Zhongda Hospital Southeast University， Nanjing 210009, Jiangsu Province, China.
- Publication Type:Journal Article
- Keywords:
ECOG score;
hematological disease;
solid tumor;
superimposed with
- MeSH:
Aged;
Female;
Hematologic Neoplasms/complications*;
Humans;
Leukemia, Myeloid, Acute/complications*;
Male;
Myelodysplastic Syndromes/complications*;
Prognosis;
Retrospective Studies
- From:
Journal of Experimental Hematology
2022;30(3):924-929
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the clinical characteristics and prognosis of hematological malignancies superimposed patients with solid tumors.
METHODS:The clinical data of 30 patients with more than two kinds of malignancy (the second is hematological malignancy) from October 2011 to October 2020 in Department of Hematology, Jiangning Hospital Affiliated to Nanjing Medical University were collected and analyzed retrospectively. The overall survival time was used as the prognostic evaluation standard, and the survival of patients were analyzed by KaplanMeier method. Logrank test and Cox regression model were used to carry out univariate and multivariate retrospective analysis on clinical and laboratory parameters of 30 patients.
RESULTS:Among 30 cases, 20 were male, 10 were female, the median age of onset of the second tumor was 70 years old. The common types of the secondary hematological malignancies to solid tumors are myelodysplastic syndrome, acute myeloid leukemia, multiple myeloma. Univariate analysis showed that patients' gender, age, type of solid tumors, the onset of interval between two kinds of tumor, chromosome karyotype were not related to do with the patients' overall survival time. Type of hematologic disease, ECOG score were associated with patients' overall survival time, and the multivariate analysis showed that the type of hematologic disease and ECOG score were independent risk factors for patients with poor prognosis.
CONCLUSION:Patients superimposed with solid tumors complicated with myelodysplastic syndrome or acute leukemia and ECOG score ≥3 have poor prognosis and shorter overall survival time, which are independent risk factors influencing the prognosis. Bone marrow injury, immune dysfunction and genetic susceptibility after chemoradiotherapy may be the main causes of these diseases.
